Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)

DIAMOND2 Study Group

Research output: Contribution to journalArticle

3 Citations (Scopus)

Fingerprint Dive into the research topics of 'Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)'. Together they form a unique fingerprint.

Medicine & Life Sciences